Literature DB >> 708026

Antimicrobial susceptibility of flavobacteria.

R C Aber, C Wennersten, R C Moellering.   

Abstract

Antimicrobial susceptibility patterns of 28 clinical isolates of Flavobacterium sp. were determined by standard disk diffusion technique and by antimicrobial dilution in agar. Rifampin, clindamycin, trimethoprim-sulfamethoxazole, cefoxitin, and vancomycin are among the antimicrobial agents which may be clinically useful to treat infections caused by flavobacteria. All 28 isolates were resistant to erythromycin with minimal inhibitory concentrations of 32 mug/ml or more. Currently recommended interpretive zones of inhibition by disk diffusion did not reliably predict antimicrobial susceptibility of the 28 flavobacteria isolates when compared with the agar dilution technique, and, therefore, a more direct measurement of minimal inhibitory or bactericidal concentration is recommended.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708026      PMCID: PMC352486          DOI: 10.1128/AAC.14.3.483

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Epidemic meningitis of the newborn caused by flavobacteria. I. Epidemiology and bacteriology.

Authors:  H A CABRERA; G H DAVIS
Journal:  Am J Dis Child       Date:  1961-03

2.  Flavobacterium infection as a cause of bacterial endocarditis. Report of a case, bacteriologic studies, and review of the literature.

Authors:  J SCHIFF; L S SUTER; R D GOURLEY; W D SUTLIFF
Journal:  Ann Intern Med       Date:  1961-09       Impact factor: 25.391

3.  Studies on a group of previously unclassified bacteria associated with meningitis in infants.

Authors:  E O KING
Journal:  Am J Clin Pathol       Date:  1959-03       Impact factor: 2.493

4.  Subacute bacterial endocarditis due to Flavobacterium meningosepticum.

Authors:  S Werthamer; M Weiner
Journal:  Am J Clin Pathol       Date:  1972-03       Impact factor: 2.493

5.  ICU-acquired pneumonia due to Flavobacterium meningosepticum.

Authors:  D Teres
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

6.  In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.

Authors:  G Altmann; B Bogokovsky
Journal:  J Med Microbiol       Date:  1971-05       Impact factor: 2.472

7.  Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin.

Authors:  E G Maderazo; H P Bassaris; R Quintiliani
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

8.  Rifamycin in neonatal flavobacteria meningitis.

Authors:  E L Lee; M J Robinson; M L Thong; S D Puthucheary
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

9.  Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species.

Authors:  W E Stamm; J J Colella; R L Anderson; R E Dixon
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

10.  Flavobacterium meningosepticum in the hospital environment.

Authors:  M M Coyle-Gilchrist; P Crewe; G Roberts
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

  10 in total
  21 in total

1.  Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 3.267

2.  Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.

Authors:  George B Christakis; Stavroula P Perlorentzou; Irene Chalkiopoulou; Athanasios Athanasiou; Nikolas J Legakis
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates.

Authors:  P R Hsueh; J C Chang; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.

Authors:  J C Chang; P R Hsueh; J J Wu; S W Ho; W C Hsieh; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Antibiotic resistance pattern of Flavobacterium meningosepticum.

Authors:  A Raimondi; F Moosdeen; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

6.  Septicemia caused by Sphingobacterium multivorum.

Authors:  J Freney; W Hansen; C Ploton; H Meugnier; S Madier; N Bornstein; J Fleurette
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

7.  Successful treatment of neonatal Flavobacterium meningosepticum infection.

Authors:  M Kaplan; M D Goldberg; Z Tauber; F Solomon; D Sompolinsky
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

8.  Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices.

Authors:  P R Hsueh; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 9.  Fatal case of necrotizing fasciitis due to Myroides odoratus.

Authors:  N F Crum-Cianflone; R W Matson; G Ballon-Landa
Journal:  Infection       Date:  2014-05-08       Impact factor: 3.553

10.  Identification of a multidrug efflux pump in Flavobacterium johnsoniae.

Authors:  Sarah E Clark; Brooke A Jude; G Russell Danner; Frank A Fekete
Journal:  Vet Res       Date:  2009-06-27       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.